These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 19414634)

  • 41. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S; Ichikawa K; Yamada K; Tanimoto M; Miki T; Otsuka H; Yamamoto K; Kawamoto K; Katayama Y; Tanakaya M; Ito H
    Int J Cardiol; 2015; 190():287-92. PubMed ID: 25932809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FGF-23 and cognitive performance in hemodialysis patients.
    Drew DA; Tighiouart H; Scott TM; Lou KV; Fan L; Shaffi K; Weiner DE; Sarnak MJ
    Hemodial Int; 2014 Jan; 18(1):78-86. PubMed ID: 24164913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of FGF23 to indexed left ventricular mass in children with non-dialysis stages of chronic kidney disease.
    Sinha MD; Turner C; Booth CJ; Waller S; Rasmussen P; Goldsmith DJ; Simpson JM
    Pediatr Nephrol; 2015 Oct; 30(10):1843-52. PubMed ID: 25975437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.
    Colbert G; Jain N; de Lemos JA; Hedayati SS
    Clin J Am Soc Nephrol; 2015 Mar; 10(3):515-29. PubMed ID: 25403922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acid Load and Phosphorus Homeostasis in CKD.
    Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
    Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of fibroblast growth Factor-23 as a correlate of cardiovascular disease among individuals with chronic kidney disease, hypertensives, and healthy controls.
    Abiola BI; Raji YR; Ajayi S; Adeoye AM; Salako BL; Arije A; Kadiri S
    Niger J Clin Pract; 2022 Aug; 25(8):1247-1255. PubMed ID: 35975371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients.
    Balci M; Kirkpantur A; Gulbay M; Gurbuz OA
    Hemodial Int; 2010 Oct; 14(4):425-32. PubMed ID: 20955275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis.
    Kestenbaum B; Sachs MC; Hoofnagle AN; Siscovick DS; Ix JH; Robinson-Cohen C; Lima JA; Polak JF; Blondon M; Ruzinski J; Rock D; de Boer IH
    Circ Heart Fail; 2014 May; 7(3):409-17. PubMed ID: 24668259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ventricular function and all-cause mortality in chronic kidney disease patients with angiographic coronary artery disease.
    Wu IW; Hung MJ; Chen YC; Hsu HJ; Cherng WJ; Chang CJ; Wu MS
    J Nephrol; 2010; 23(2):181-8. PubMed ID: 20119930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma neutrophil gelatinase-associated lipocalin is independently associated with left ventricular hypertrophy and diastolic dysfunction in patients with chronic kidney disease.
    Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
    PLoS One; 2018; 13(10):e0205848. PubMed ID: 30325973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension.
    Suzuki M; Yamamoto K; Watanabe S; Iwata T; Hamada M; Hiwada K
    Am J Med; 2000 Jun; 108(8):627-33. PubMed ID: 10856410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.
    Arita Y; Nakayama M; Matsukuma Y; Yoshitomi R; Seki M; Fukui A; Tsuda S; Sonoda Y; Imazu R; Arakawa K; Tominaga M; Nakano T; Tsuruya K; Kitazono T
    BMC Nephrol; 2020 May; 21(1):203. PubMed ID: 32471374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
    Deo R; Katz R; de Boer IH; Sotoodehnia N; Kestenbaum B; Mukamal KJ; Chonchol M; Sarnak MJ; Siscovick D; Shlipak MG; Ix JH
    Am J Kidney Dis; 2015 Jul; 66(1):40-6. PubMed ID: 25572028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PTH, FGF-23 and early CKD.
    Rodriguez M; Felsenfeld AJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347
    [No Abstract]   [Full Text] [Related]  

  • 60. Alpha Klotho and Fibroblast Growth Factor-23 Among Alcoholics.
    Quintero-Platt G; González-Reimers E; Rodríguez-Gaspar M; Martín-González C; Pérez-Hernández O; Romero-Acevedo L; Espelosín-Ortega E; Vega-Prieto MJ; Santolaria-Fernández F
    Alcohol Alcohol; 2017 Sep; 52(5):542-549. PubMed ID: 28651327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.